WHO Outlines Recommendations to Protect Infants Against RSV – Respiratory Syncytial Virus
The WHO just issued its first paper on **RSV immunization** for infants, vital since RSV is the top cause of fatal acute lower respiratory infections in young children globally.
Today, the World Health Organization (WHO) published its first-ever position paper on immunization products to protect infants against respiratory syncytial virus (RSV) – the leading cause of acute lower respiratory infections in children globally.
Every year, RSV causes about 100 000 deaths and over 3.6 million hospitalizations in children under the age of 5 years worldwide. About half of these deaths occur in infants younger than 6 months of age. The vast majority (97%) of RSV deaths in infants occur in low- and middle-income countries where there is limited access to supportive medical care, such as oxygen or hydration.
Click here to access the article.